Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2018-003464-32Phase 4Completed
Phase 4, single-arm trial of mirtazapine in Focal Onset Epilepsy. Primary endpoint: Changes in seizure frequency. Started Nov 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2018-003464-32.